Non-small cell lung cancer

You have access
Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
YUJI NOJIMA, KATSUHIKO SHIMIZU, SHINSUKE SAISHO, AI MAEDA, TAKESHI KUROSAKI, KOJI KUROSE, TORU OGA, MIKIO OKA and MASAO NAKATA

Anticancer Research November 2021, 41 (11) 5469-5475; DOI: https://doi.org/10.21873/anticanres.15359
You have access
Positive Correlation Between the Number of Circulating Tumor Cells in the Pulmonary Vein and Tumor Spread Through Air Spaces in Resected Non-small Cell Lung Cancer
HIROAKI KURODA, KATSUHIRO MASAGO, YUSUKE TAKAHASHI, SHIRO FUJITA, EIICHI SASAKI, TAKEO NAKADA, NORIAKI SAKAKURA, HAYAO NAKANISHI, HIROKAZU MATSUSHITA and YASUSHI YATABE

Anticancer Research November 2021, 41 (11) 5499-5505; DOI: https://doi.org/10.21873/anticanres.15363
You have access
Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease
TAKASHI SAITO, KAYOKO OHNISHI, HITOSHI ISHIKAWA, MASATOSHI NAKAMURA, SODAI HOSHIAI, HARUKO NUMAJIRI, KEIKO NEMOTO MUROFUSHI, MASASHI MIZUMOTO, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI

Anticancer Research November 2021, 41 (11) 5635-5642; DOI: https://doi.org/10.21873/anticanres.15379
You have access
Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer
MASAYUKI FUJIWARA, HIROSHI DOI, MASATAKA IGETA, HITOMI SUZUKI, KAZUHIRO KITAJIMA, MASAO TANOOKA, TOSHIHISA ISHIDA, TSUKASA WAKAYAMA, TAKASHI YOKOI, KOZO KURIBAYASHI, TAKASHI KIJIMA, MASAKI HASHIMOTO, NOBUYUKI KONDO, SEIJI MATSUMOTO, SEIKI HASEGAWA, NORIHIKO KAMIKONYA and KOICHIRO YAMAKADO

Anticancer Research November 2021, 41 (11) 5793-5802; DOI: https://doi.org/10.21873/anticanres.15396
You have access
Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy
KAZUYUKI HAMADA, KIYOSHI YOSHIMURA, YUYA HIRASAWA, MASAHIRO HOSONUMA, MASAKAZU MURAYAMA, YOICHIRO NARIKAWA, HIROTSUGU ARIIZUMI, RYOTARO OHKUMA, MIDORI SHIDA, YUTARO KUBOTA, SATOSHI MATSUKUMA, TOMOYUKI ISHIGURO, TAKEHIKO SAMBE, ATSUSHI HORIIKE, ATSUO KURAMASU, SATOSHI WADA, JUNJI TSURUTANI, EISUKE INOUE, NAOKI UCHIDA, YUJI KIUCHI, SHINICHI KOBAYASHI, ROBERT M. HOFFMAN and TAKUYA TSUNODA

Anticancer Research October 2021, 41 (10) 4985-4993; DOI: https://doi.org/10.21873/anticanres.15312
Open Access
Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer
SUNIL KUMAR SURAPANENI, EBONY NOTTINGHAM, ARINDAM MONDAL, NILKUMAR PATEL, PEGGY ARTHUR, ARAGAW GEBEYEHU, ANIL KUMAR KALVALA, ARUN K. RISHI and MANDIP SINGH

Anticancer Research September 2021, 41 (9) 4215-4228; DOI: https://doi.org/10.21873/anticanres.15226
You have access
Possible Pseudo-progression of Non-small Cell Lung Carcinoma in a Patient With Clinical Hyper-progression Associated With Trousseau Syndrome Who Was Treated With Pembrolizumab: A Case Report
YOSUKE SHIONOYA, YOSHIHIKO HIROHASHI, HARUKA TAKAHASHI, MIDORI HASHIMOTO, KAORU NISHIYAMA, YASUNARI TAKAKUWA, MUNEHIDE NAKATSUGAWA, TERUFUMI KUBO, TAKAYUKI KANASEKI, TOMOHIDE TSUKAHARA and TOSHIHIKO TORIGOE

Anticancer Research July 2021, 41 (7) 3699-3706; DOI: https://doi.org/10.21873/anticanres.15161
You have access
Lenvatinib Induces AKT/NF-κB Inactivation, Apoptosis Signal Transduction and Growth Inhibition of Non-small Cell Lung Cancer In Vivo
YU-CHANG LIU, FEI-TING HSU, JING-GUNG CHUNG, MAO-CHI WENG, CHIEN-YI TING, CHIA-JUNG TSAI, ALEXANDER LAN, JENG-YUAN WU, CHARLES CHUNG-WEI LIN and SONG-SHEI LIN

Anticancer Research June 2021, 41 (6) 2867-2874; DOI: https://doi.org/10.21873/anticanres.15068
You have access
DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling
HARDYANTI EKA PUTRI, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE

Anticancer Research June 2021, 41 (6) 2913-2923; DOI: https://doi.org/10.21873/anticanres.15073
You have access
The Prognostic Value of Programmed Death-ligand 1 (PD-L1) in Patients who Received Neoadjuvant Chemoradiation Therapy Followed by Surgery for Locally Advanced Non-small Cell Lung Cancer
GEUN DONG LEE, BYUNGKWON CHUNG, JOON SEON SONG, SE JIN JANG and HYEONG RYUL KIM

Anticancer Research June 2021, 41 (6) 3193-3204; DOI: https://doi.org/10.21873/anticanres.15106

Main menu

User menu

Search

Non-small cell lung cancer

Pages